By spha spha  on Wed, Apr 8, 2009 - 0 Comments
Categories: General

• Tweet

SPHA Bi-Weekly Update
Week of 3/23/08 

First Annual Mixer
Please join us for our FIRST SPHA's ANNUAL MIXER for Full-timers, Part-timers and Alumni! We are inviting professor Cliff Bleustein and professor Sheila Wellington to our event as well. Both have long-standing experience in heatlhcare and public health. This is an excellent opportunity to reunite with fellow students and meet alumni and professionals.

Note: We will provide food and refreshments!  

See RSVP link at the bottom of this e-mail. 

Healthcare in the News

Brain Researchers Open Door to Editing Memory  
Researchers have made significant strides in understanding how memory works and have even experimented with blocking or removing memories in animal experiments.

3 Researchers at Harvard Are Named in Subpoena  
Researchers at Harvard are being subpoenaed for their involvement in research related to the promotion of an antipsychotic medication for use in children. Lawmakers are investigating conflicts of interest in medicine (the researcher received significant consulting fees from drug makers) and how it has affected Medicaid spending.

Researchers Square Off on Disclosure  
In related news, researchers are debating the issue of disclosure when it comes to industry paid consulting or speaking fees that might represent a conflict of interest.

Drug Makers Told to Stop Using Some Internet Ads  
The FDA has ordered a number of drug manufacturers to cease placing certain types of ads, such as some keyword related ads on google searches.

Democrats Target Deals to Delay Generics  (WSJ, may require subscription)
Democratic lawmakers are seeking to outlaw payments from large pharmaceutical companies to generic manufacturers to delay the launch of generic versions (such is currently the case with Pfizer’s Lipitor).

Eli Lilly Is on Hunt for Acquisitions  (WSJ, may require subscription)
Acquisitions continue to be a popular topic in the pharma sector as Eli Lilly has indicated they are pursuing up to $15 billion in new acquisitions.

Genzyme Buys Rights To MS Drug  (WSJ, may require subscription)
Genzyme has purchased the rights to a potentially promising MS treatment from Bayer along with 2 cancer treatments. Similar to many other recent deals, the amount Genzyme will pay Bayer depends on the drug’s success.

Solvay Will Seek Buyers for Drug Division  (WSJ, may require subscription)
Solvay is looking to sell its pharmaceutical division to capitalize on the growth in acquisitions in the sector.

Doctors Urge Limits on Drug Firm Money  (WSJ, may require subscription)
Doctors are pushing medical associations that develop important guidelines and standards of practice for physicians to no longer accept funding from pharmaceutical companies.

Please send comments/suggestions to gb986@stern.nyu.edu.

RSVP!

Event: SPHA Annual Mixer - Dove When: Thu, Apr 16, 2009 at 16:25 (ends on Thu, Apr 16, 2009 at 20:00) Where: Dove 228 Thompson Street btw 3rd and Bleecker

RSVP